Cellular receptor for the human polyomavirus, JCV
人多瘤病毒 (JCV) 的细胞受体
基本信息
- 批准号:6731202
- 负责人:
- 金额:$ 25.23万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1997
- 资助国家:美国
- 起止时间:1997-09-01 至 2007-03-31
- 项目状态:已结题
- 来源:
- 关键词:HeLa cellsPolyomavirus hominis 2affinity chromatographyastrocytesbinding proteinscell membraneconfocal scanning microscopygenetic libraryglycosylationhuman genetic material taghuman tissueimmunocytochemistryimmunoprecipitationlaboratory mouselaboratory rabbitmass spectrometrymonoclonal antibodyoligodendrogliaprotein sequencereceptor bindingreceptor expressionsimian virus 40transfection /expression vectorvirus infection mechanismvirus receptors
项目摘要
DESCRIPTION (provided by applicant): The initial event in the life cycle of a
virus is its interaction with receptors present on the surface of a cell.
Understanding these interactions is important to our understanding of viral
tropism, spread, and pathogenesis. The human polyomavirus, JCV, is the
etiological agent of the fatal central nervous system (CNS) demyelinating
disease, progressive multifocal leukoencephalopathy (PML). JCV has also been
associated with several human tumors, including oligoastrocytoma and
medulloblastoma. Following primary infection, JCV establishes a lifelong
persistent infection in kidney and lymphoid tissues. In a minority of
individuals, the virus spreads to the CNS, infecting both oligodendrocytes and
astrocytes. The mechanisms that restrict JCV tropism for these cells and
tissues and the mechanisms that allow for the spread of JCV from the periphery
to the CNS are not understood. Our laboratory has been studying early events in
the life cycle of JCV. We have determined that: 1. an N-linked glycoprotein
containing terminal alpha (2-6) linked sialic acid is a critical component of
the JCV receptor; 2. JCV and the related polyomavirus, SV40, do not share
receptor specificity; and, 3. JCV, unlike SV40, enters cells by clathrin
dependent receptor mediated endocytosis. The long term goals of our research
are to define the role of virus receptors in mediating infection of cells and
in determining viral tropism, spread, and pathogenesis in the infected host.
Our working hypothesis, which is based on our previous work, is that JCV
receptor interactions are critical determinants of viral entry, tropism, and
spread within the host. We will address this hypothesis by asking the following
questions: 1. What is the identity of the JCV receptor? 2. What are the cell
and tissue distributions of JCV receptors? and 3. How does JCV penetrate the
plasma membrane and target its genome to the nucleus? The data resulting from
these studies will yield novel insights into the pathogenesis of JCV induced
disease and may lead to novel therapies to prevent or treat these diseases.
描述(由申请人提供):生命周期中的初始事件
病毒与细胞表面受体的相互作用。
了解这些相互作用对我们理解病毒的
向性、传播和发病机制。人类多瘤病毒,JCV,是
致死性中枢神经系统(CNS)脱髓鞘的病原体
进行性多灶性白质脑病(PML)。JCV也被
与几种人类肿瘤相关,包括寡星形细胞瘤和
髓母细胞瘤在初次感染后,JCV建立了一个终身的
肾脏和淋巴组织持续感染。在少数
在个体中,病毒传播到CNS,感染少突胶质细胞和
星形胶质细胞。限制JCV对这些细胞的嗜性的机制,
组织和机制,使JCV从周边扩散
中枢神经系统还不清楚。我们的实验室一直在研究
JCV的生命周期我们已经确定:1。N-连接糖蛋白
含有末端α(2-6)连接的唾液酸是
JCV受体; 2. JCV和相关的多瘤病毒SV 40不共享
受体特异性;和,3.与SV 40不同,JCV通过网格蛋白进入细胞
依赖受体介导的内吞作用。我们研究的长期目标
是为了确定病毒受体在介导细胞感染中的作用,
在确定病毒在受感染宿主中的嗜性、传播和发病机制方面。
我们的工作假设,这是基于我们以前的工作,是JCV,
受体相互作用是病毒进入、嗜性和
在宿主体内传播。我们将通过提出以下问题来解决这个假设
问题:1. JCV受体的身份是什么?2.什么是细胞
JCV受体的组织分布和3. JCV如何渗透到
质膜并将其基因组定位到细胞核?数据来源于
这些研究将对JCV诱导的发病机制产生新的见解,
并可能导致新的疗法来预防或治疗这些疾病。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Walter J Atwood其他文献
Walter J Atwood的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Walter J Atwood', 18)}}的其他基金
Progressive Multifocal Leukoenephalopathy: Endemic Viruses and Lethal Brain Disease
进行性多灶性白质脑病:地方性病毒和致命性脑病
- 批准号:
10393583 - 财政年份:2020
- 资助金额:
$ 25.23万 - 项目类别:
Progressive Multifocal Leukoenephalopathy: Endemic Viruses and Lethal Brain Disease
进行性多灶性白质脑病:地方性病毒和致命性脑病
- 批准号:
10604314 - 财政年份:2020
- 资助金额:
$ 25.23万 - 项目类别:
Structure-function based development of JC virion specific antagonists for PML
基于结构-功能的 JC 病毒颗粒特异性 PML 拮抗剂的开发
- 批准号:
8304292 - 财政年份:2009
- 资助金额:
$ 25.23万 - 项目类别: